Our results showed linear, up-regulation of Prdx3 and Gpx1 in the middle section of small intestine; this can activate antioxidant processes that are relevant for bacteria-associated inflammation, cancer-promoting conditions and tumor progression. Here, PRDX3 is linked to neoplasm.